SHZ · 300482.SZ
Guangzhou Wondfo Biotech Co.,Ltd
CN¥15.98-CN¥0.10 (-0.62%)
Guangzhou Wondfo Biotech Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 39.22% below the high.
Loading market information…
SHH · 603392.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 60.71% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.’s forward annual dividend is CN¥0.32 per share, paid annual. The forward yield is 1.39% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.’s next earnings report is currently expected on Mar 25, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical firm that handles the entire process from research and development to the production, marketing, and distribution of diagnostic solutions for infectious diseases and various vaccines. The company operates extensively across China and in international markets. Its comprehensive product range offers diagnostic test kits for a multitude of infectious agents, including COVID-19, HIV, HTLV, Hepatitis, EV-71, and Tuberculosis. It also provides specific detection reagents for Hepatitis C and Syphilis. Beyond these, the portfolio includes advanced diagnostic tools such as automated immunoassays, ELISA kits, rapid diagnostic tests, and various chemiluminescence, clinical chemistry, and general immunodiagnostic reagents. Furthermore, Beijing Wantai is a developer and supplier of vaccines for Hepatitis E and human papillomavirus (HPV). The company serves a wide array of clients, including blood banks, hospitals and clinics, specialized reference laboratories, border inspection centers, blood-processing companies, and scientific research institutes. Established in 1991, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is headquartered in China's capital city, Beijing.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:27 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Apr 11, 2025 |
| CN¥0.25-74.78% vs estimate |
| CN¥1.38B-54.03% vs estimate |
| Q3 2024 | Oct 24, 2024 | CN¥0.01-90.91% vs estimate | CN¥582.07M-17.52% vs estimate |
|---|
| Q2 2024 | Aug 22, 2024 | CN¥0.11-35.29% vs estimate | CN¥601.24M-81.67% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥15.98-CN¥0.10 (-0.62%)
Guangzhou Wondfo Biotech Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 39.22% below the high.
CN¥12.46-CN¥0.04 (-0.32%)
Beijing Strong Biotechnologies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 22.37% below the high.
CN¥66.93-CN¥3.36 (-4.78%)
Beijing Hotgen Biotech Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 68.84% below the high.
CN¥10.76-CN¥0.49 (-4.36%)
Shenzhen YHLO Biotech Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 36.71% below the high.
CN¥37.84+CN¥0.31 (+0.83%)
Hangzhou Biotest Biotech Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.77% below the high.
CN¥5.90+CN¥0.30 (+5.36%)
Beijing Leadman Biochemistry Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.32% below the high.
CN¥21.80-CN¥0.93 (-4.09%)
Jiangsu Bioperfectus Technologies Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 65.68% below the high.
CN¥25.86-CN¥0.80 (-3.0%)
Beijing Succeeder Technology Inc.’s quoted price sits in the lower half of its reported 52-week range, 28.33% below the high.
